SI9620053A - Antiglukokortikoidno zdravilo - Google Patents

Antiglukokortikoidno zdravilo Download PDF

Info

Publication number
SI9620053A
SI9620053A SI9620053A SI9620053A SI9620053A SI 9620053 A SI9620053 A SI 9620053A SI 9620053 A SI9620053 A SI 9620053A SI 9620053 A SI9620053 A SI 9620053A SI 9620053 A SI9620053 A SI 9620053A
Authority
SI
Slovenia
Prior art keywords
pheromones
glucocorticoid
antiglucocorticoid
pheromone
aliphatic
Prior art date
Application number
SI9620053A
Other languages
English (en)
Slovenian (sl)
Inventor
Sergei Dmitrievich Burlakov
Dmitry Dmitrievich Genkin
Kirill Gennadievich Surkov
Viktor Veniaminovich Tets
Original Assignee
Sergei Dmitrievich Burlakov
Dmitry Dmitrievich Genkin
Kirill Gennadievich Surkov
Viktor Veniaminovich Tets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sergei Dmitrievich Burlakov, Dmitry Dmitrievich Genkin, Kirill Gennadievich Surkov, Viktor Veniaminovich Tets filed Critical Sergei Dmitrievich Burlakov
Publication of SI9620053A publication Critical patent/SI9620053A/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Securing Of Glass Panes Or The Like (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
SI9620053A 1996-01-31 1996-02-01 Antiglukokortikoidno zdravilo SI9620053A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU96101194/14A RU2125446C1 (ru) 1996-01-31 1996-01-31 Антиглюкокортикоидное лекарственное средство
PCT/RU1996/000028 WO1997027845A1 (fr) 1996-01-31 1996-02-01 Medicament a base d'anti-glucocorticoide

Publications (1)

Publication Number Publication Date
SI9620053A true SI9620053A (sl) 1998-04-30

Family

ID=20175968

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9620053A SI9620053A (sl) 1996-01-31 1996-02-01 Antiglukokortikoidno zdravilo

Country Status (24)

Country Link
US (1) US5965623A (et)
EP (1) EP0896819A4 (et)
JP (1) JPH11504946A (et)
KR (1) KR100347862B1 (et)
CN (1) CN1213964A (et)
AU (1) AU710479B2 (et)
BG (1) BG102709A (et)
BR (1) BR9612470A (et)
CA (1) CA2244985A1 (et)
CZ (1) CZ160598A3 (et)
EE (1) EE9800209A (et)
GE (1) GEP20001955B (et)
HU (1) HUP9900504A2 (et)
LT (1) LT4441B (et)
LV (1) LV12177B (et)
MD (1) MD1430B1 (et)
MX (1) MX9806182A (et)
NO (1) NO983508L (et)
PL (1) PL187564B1 (et)
RU (1) RU2125446C1 (et)
SI (1) SI9620053A (et)
SK (1) SK65598A3 (et)
UA (1) UA48212C2 (et)
WO (1) WO1997027845A1 (et)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001039766A2 (en) * 1999-12-01 2001-06-07 Alydar Pharmaceuticals Ltd. Screening invertebrate pheromones for therapeutic activity
US6548706B2 (en) * 1999-12-23 2003-04-15 Aerojet Fine Chemicals Llc Preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl) -p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
EP1409656A4 (en) * 2001-03-12 2005-01-12 Darley Pharmaceuticals Ltd SCREENING OF PHEROMONAL COMPOUNDS OF NON-STEROID AND NON-PEPTIDE INVERTEBRATE HAVING ACTIVITY MODULATING MITOGEN-ACTIVATED PROTEIN KINASE
US6806293B1 (en) 2001-03-12 2004-10-19 Darley Pharmaceuticals Ltd Use of pheromone compounds having MAP kinase modulating activity
WO2003092614A2 (en) * 2002-05-02 2003-11-13 Hickle Randall S Lipid removal from the body
US6752649B2 (en) * 2002-11-07 2004-06-22 Xentris, Llc Illuminated indicia power supply apparatus and method of manufacture
DE10335845B4 (de) * 2003-05-09 2006-08-31 Müller, Martina, Dr.med. Pheromone als Antikrebsmittel
WO2010017177A1 (en) * 2008-08-06 2010-02-11 The Trustees Of The University Of Pennsylvania Ultrasonically induced release from polymer vesicles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US161926A (en) 1875-04-13 Improvement in ink-wells
US2900756A (en) * 1958-12-09 1959-08-25 Jacobson Martin Attractants for the gypsy moth
EP0149847A3 (en) * 1983-12-26 1989-11-08 Eisai Co., Ltd. Therapeutic and preventive agent containing dolichol
JPH0759504B2 (ja) * 1986-01-23 1995-06-28 エーザイ株式会社 ポリプレニルアルコ−ル含有注射剤
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
US4740627A (en) * 1987-05-21 1988-04-26 Phillips Petroleum Company Synthesis of E,Z-11-tetradecen-1-al
DE68902753T2 (de) 1988-02-29 1993-01-21 Pfizer Mittel zur erhoehung des transdermalen penetrationsflusses.
US5190978A (en) * 1989-09-29 1993-03-02 Dai-Ichi Kogyo Seiyaku Co. Ltd. Carcinostatic compositions and methods

Also Published As

Publication number Publication date
EE9800209A (et) 1998-12-15
KR19990076946A (ko) 1999-10-25
PL187564B1 (pl) 2004-08-31
GEP20001955B (en) 2000-03-05
AU4636396A (en) 1997-08-22
KR100347862B1 (ko) 2003-01-24
LV12177B (lv) 1999-06-20
HUP9900504A2 (en) 1999-09-28
LT4441B (lt) 1999-01-25
MD1430B1 (ro) 2000-03-31
AU710479B2 (en) 1999-09-23
LT98054A (en) 1998-10-26
RU2125446C1 (ru) 1999-01-27
CZ160598A3 (cs) 1998-08-12
BR9612470A (pt) 1999-07-13
UA48212C2 (uk) 2002-08-15
CA2244985A1 (en) 1997-08-07
NO983508D0 (no) 1998-07-30
PL322596A1 (en) 1998-02-02
NO983508L (no) 1998-07-30
EP0896819A1 (en) 1999-02-17
BG102709A (en) 1999-06-30
LV12177A (lv) 1998-12-20
US5965623A (en) 1999-10-12
SK65598A3 (en) 1998-09-09
JPH11504946A (ja) 1999-05-11
MX9806182A (es) 1998-10-31
CN1213964A (zh) 1999-04-14
WO1997027845A1 (fr) 1997-08-07
EP0896819A4 (en) 2001-11-07

Similar Documents

Publication Publication Date Title
AU2003231943B2 (en) Topical drug delivery using phosphatidylcholine
AU2003267131B2 (en) Formulation for lipophilic agents
US4397867A (en) Treatment of arthritic complaints
DE69909127T2 (de) Aerosol formulierungen für buccale und pulmonale anwendung
JP2002513748A (ja) ゲル化性薬剤組成物
EP0055029B1 (en) Preparations for the treatment of dermatoses
JP5873439B2 (ja) ビタミンd類似体および溶媒と界面活性剤の混合物を含む皮膚組成物
EP0126580A2 (en) Vesicle formulations for the controlled release of therapeutic agents
SI9620053A (sl) Antiglukokortikoidno zdravilo
WO2000033917A1 (de) Mittel zur tumortherapie auf liposomenbasis die tamoxifen enthalten
US20030199476A1 (en) Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof
JPS59222410A (ja) 薬物保持リポソ−ム製剤
Canepa et al. A study of lipotropic factors derived from the pancreas
JPS60152410A (ja) 皮膚外用剤
Hendradi et al. THE INFLUENCE OF NIOSOME SYSTEM (SPAN 20/60-CHOLESTEROL) ON THE PREPARATION CHARACTERISTICS AND RELEASED OF DICLOFENAC SODIUM FROM GEL CARBOPOL ETD
CZ20004010A3 (cs) Farmaceutické kompozice schopné vytvářet gel

Legal Events

Date Code Title Description
KO00 Lapse of patent

Effective date: 20041028